Market Tracker

07/29 5:16pm ET

Neurocrine Biosciences Inc (NASDAQ:NBIX)

50.23
Delayed Data
As of Jul 29
 +0.08 / +0.16%
Today’s Change
31.25
Today|||52-Week Range
58.46
-11.21%
Year-to-Date
No recent news for Neurocrine Biosciences Inc.

Today’s Trading

Previous close50.15
Today’s open49.83
Day’s range48.74 - 50.33
Volume617,141
Average volume (3 months)1,096,823
Market cap$4.4B
Dividend yield--
Data as of 3:59pm ET, 07/29/2016

Growth & Valuation

Earnings growth (last year)-29.63%
Earnings growth (this year)-84.05%
Earnings growth (next 5 years)-9.18%
Revenue growth (last year)--
P/E ratioNM
Price/Sales241.79
Price/Book10.21

Competitors

 Today’s
change
Today’s
% change
JUNOJuno Therapeutics In...+1.02+3.41%
CTLTCatalent Inc-0.11-0.43%
XONIntrexon Corp+0.62+2.51%
KITEKite Pharma Inc+2.11+3.87%
Data as of 4:02pm ET, 07/29/2016

Financials

Last reporting dateJuly 27, 2016
EPS forecast (this quarter)-$0.49
Annual revenue (last year)$19.8M
Annual profit (last year)-$88.9M
Net profit margin-449.84%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Kevin Charles Gorman
Vice President-Information Technology &
Operations
Bill Wilson
Corporate headquarters
San Diego, California

Forecasts